百達精工(603331.SH):2022年度擬向相關金融機構申請總額不超7億元綜合授信額度
格隆匯4月12日丨 百達精工(603331.SH)公佈,為滿足公司生產經營業務需要,2022年度公司及納入公司合併報表的子公司擬向相關金融機構申請總額不超過人民幣7億元的綜合授信額度,且在同一銀行內累計不超過2.5億,並以公司合法擁有的財產作為上述綜合授信的抵押物或質押物。上述額度在授權有效期內可滾動使用。
為了提高資金運用效率,現提議授權董事長在上述額度範圍內與各金融機構商討有關授信及融資業務,並代表公司及子公司簽署有關協議,授權有效期至2022年年度股東大會召開日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.